ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Amundi STOXX Europe 600 Consumer Discretionary UCITS ETF

Amundi STOXX Europe 600 Consumer Discretionary UCITS ETF (TRV)

30.03
-0.457
(-1.50%)
Closed February 08 11:30AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
30.03
Bid
29.89
Ask
30.50
Volume
689
30.03 Day's Range 30.286
0.00 52 Week Range 0.00
Previous Close
30.487
Open
30.192
Last Trade
355
@
30.03
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

TRV Latest News

MARKET SNAPSHOT: U.S. Stocks Brace For More Earnings

By Nick Godt With mixed reports from bellwethers denting enthusiasm for the rally in stocks, investors await one of the busiest weeks of the third-quarter earnings season hoping that key results...

AIG's Loss Of Commercial Business Less Than Expected - UBS

By Alistair Barr American International Group's (AIG) share of the commercial insurance market hasn't dropped as much as expected since the company was bailed out last year by the government, UBS...

Critical Alerts For Exxon Mobil, Lockheed Martin, Travelers, US Airways, and Illumina Released By Seven Summits Research

CHICAGO, Sept. 18 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for XOM, LMT, TRV, LCC, and ILMN. Seven Summits Strategic Investments' PriceWatch Alerts are available at...

US EARNINGS WRAP: Exxon Profit Slumps; MasterCard's Is Strong

Below is a synopsis of major quarterly releases from Thursday morning: Exxon Earnings Slump 66%, Missing Views Exxon Mobil Corp.'s (XOM) second-quarter profit tumbled a larger-than-projected 66...

UPDATE: Travelers 2Q Inc Falls 21%, Raises Full-Year Outlook

(Rewords and adds information on premium rates in fifth paragraph; word change in penultimate paragraph; year-to-date stock change added in final paragraph.) DOW JONES NEWSWIRES Travelers Cos...

Travelers 2Q Income Falls 21%, Raises Full-Year Outlook

Travelers Cos.' (TRV) second-quarter income fell 21% on lower revenue and higher claims costs. But the commercial and personal insurance provider still raised its full-year earnings outlook, to...

MARKET SNAPSHOT: Blue Chips Lag As Recovery Favors Growth Plays

By Laura Mandaro The sudden contraction in U.S. consumer spending and global liquidity that brought some of America's most revered companies to their knees has made the Dow Jones Industrial...

MARKET SNAPSHOT: Blue Chips Lag As Recovery Favors Growth Plays

By Laura Mandaro The sudden contraction in U.S. consumer spending and global liquidity that brought some of America's most revered companies to their knees has made the Dow Jones Industrial...

MARKET SNAPSHOT: Blue Chips Lag As Recovery Favors Growth Plays

By Laura Mandaro The sudden contraction in U.S. consumer spending and global liquidity that brought some of America's most revered companies to their knees has made the Dow Jones Industrial...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000SP
40000000SP
120000000SP
260000000SP
520000000SP
1560000000SP
2600000000SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MGOLMGO Global Inc
$ 0.4191
(126.54%)
780.46M
CDTConduit Pharmaceuticals Inc
$ 2.831
(82.65%)
140.32M
GSIWGarden Stage Ltd
$ 0.79
(78.73%)
215.16M
TOIIWOncology Institute Inc
$ 0.033
(58.88%)
7.27k
CYTHCyclo Therapeutics Inc
$ 1.19
(54.55%)
72.39M
FTELFitell Corporation
$ 2.70
(-57.01%)
2.28M
SGBXSafe and Green Holdings Corporation
$ 0.6401
(-44.82%)
5.15M
NKLANikola Corporation
$ 0.4432
(-41.10%)
47.43M
PLRXPliant Therapeutics Inc
$ 7.785
(-34.85%)
6.4M
LIPOLipella Pharmaceuticals Inc
$ 3.08
(-33.76%)
2.08M
MGOLMGO Global Inc
$ 0.4191
(126.54%)
816.59M
RIMEAlgorhythm Holdings Inc
$ 0.0169
(-20.66%)
274.2M
NVDANVIDIA Corporation
$ 129.84
(0.90%)
228.2M
GSIWGarden Stage Ltd
$ 0.79
(78.73%)
219.64M
BHATBlue Hat Interactive Entertainment Technology
$ 0.0537
(14.74%)
212.29M

Discussion

View Full Feed
B402 B402 5 minutes ago
It was the ability to sentence question they answered.....
Shev11 Shev11 6 minutes ago
Hey guys I just read PRE 14a on there website and looks like there gonna need another extension even after March 14th which is the current termination date. The board believes there will not be sufficient time before June 14 2025 to complete the business combination. They need approvel of atleast 65
GTCH
Ayock Ayock 6 minutes ago
Those who ban books are never the good guys
https://scontent-lax3-1.xx.fbcdn.net/v/t39.30808-6/475660543_1029525139202409_4190329433910675118_n.jpg?_nc_cat=105&ccb=1-7&_nc_sid=833d8c&_nc_ohc=3LnhfZ-5Tl8Q7kNvgGVSE68&_nc_oc=AdhvplKPkuaW6WRgEiCuu1-59ah6Xyzd6OY9lmFyqo4qUTQNaC5XGTbhnsmk4xHSJ0M3QL
fuagf fuagf 7 minutes ago
Your people are endangering people worldwide and diminishing respect for America.
LakeshoreLeo1953 LakeshoreLeo1953 8 minutes ago
After 38 days fermenting you would think it would get better.
Alas, history suggests NOT.
AVXL
bbotcs bbotcs 8 minutes ago
wadegarret: AESI
The company's debt-to-cash ratio does not impress me. The recent offering is priced at $23, and with the stock at $21 a share, who is going to buy shares at $23? Is the dividend safe if they cannot finance the acquisition from the stock sale? A momentum stock advisor has
fuagf fuagf 8 minutes ago
Did the court reject Trump's request that sentencing be delayed?
Gmenfan Gmenfan 9 minutes ago
So if you die in the shower you wear your birthday suit for eternity? ;-)
Vexari Vexari 9 minutes ago
Must have been a cloudy day
starric starric 11 minutes ago
That was a fantastic conference from what I've been told. My co-worker's husband who oversaw a Charles River lab here in MA attended. He's not with Charles River anymore. Dana Farber and BIDMC are working towards building a new hospital here in Boston,  he's working on that now. 

NWBO
prototype_101 prototype_101 11 minutes ago
Wrong!!!! Prototyping is MOST CERTAINLY done under NDA's and Lebby was working with the largest Transceiver makers on 3 continents under NDA"s

Gemini, would Lightwave Logic prototyping of PIC's with Tier 1 Transceiver makers be done under NDA's?

While I cannot provide d
LWLG
Angelmin Angelmin 11 minutes ago
Great letter! 
It is obvious that Trump aims to win the midterm elections. Please send it to him for a friendly reminder. 
FNMA
SC8 SC8 11 minutes ago
Thank you for acknowledging these endless meetings have all been at the request of MK, not FDA. That's the point. Per FDA website, following submission of anything during the pre-sub program and upon receipt of FDA comments on that submission, the submitter can request an optional meeting for furt
RDGL
bar1080 bar1080 11 minutes ago
Here come DEEP Trump Cuts to biomed research. Front page news everywhere. Way overdue.
MRKR
stockprofitter stockprofitter 11 minutes ago
Post the link on Reddit, StickTwits and everywhere else known to human mankind.
FNMA
fuagf fuagf 12 minutes ago
thecrusher2011, Are you ever going to express any concern about
constitutional and other legal violations by Trump and Musk?
WALLnut WALLnut 12 minutes ago
Your desperation to label this a failure is showing. Let’s talk about what actual failure looks like. Failure is when a treatment is deemed unsafe, ineffective, or abandoned. That’s not the case here. The fact is that the tumor has already shown a response, and the study is ongoing. No one—except yo
RDGL
TightCoil TightCoil 13 minutes ago
What do you think of this:
My next door neighbor (a janitor at the local high school) told me to SELL ALL of my FNMA AND FMCC the next time we get back up closer to $7.00 then, if we go back
to back down to the $5.50 range, BUY IT ALL BACK at that lower price, i will stilll
FMCC
dstock07734 dstock07734 13 minutes ago
The vaccine targets five antigens VHL, PBRM1, BAP1, KDM5C, PIK3CA. It happens that some of those antigens also exist in three types of brain tumors. DCVax-L in combination with poly-iclc can certainly fix those highly mutated genes. Here I am talking about the version of DCVax-L developed fifteen ye
MRNA
janice shell janice shell 14 minutes ago
...you do understand in America there are 5 major religions

And so many more that parents could insist the kids in their local schools be exposed to. Like... Wicca!! Let's start with that!!
droopyeyes droopyeyes 14 minutes ago
Why don't u just stfu and let the company do its thing clown

imo 
UMAV
CatfishHunter CatfishHunter 14 minutes ago
I wouldn't even call Betaglue a competitor. They only have one documented patient that was in clinical trials back in 2022 and that's gone nowhere. BetaScam not even worth taking seriously. 
RDGL
B402 B402 15 minutes ago
The people we give the money to will not cooperate with accountability......Even the UN,

Is that how people like Hamas end up with millions as their people starve?

So we have no idea what so ever how much of the aid money make it to the front lines.....
chereb19 chereb19 15 minutes ago
The primary objective of this phase I trial is to assess the safety and feasibility of the treatment.
Notably, one patient experienced an exceptional 80% reduction in tumor size during this trial so far. Such a significant response is uncommon in phase I trials, which are primarily designed t
RDGL
Rich4863 Rich4863 15 minutes ago
So Git, Do you like to wish harm to someone who has never spread lies about you like you claim?
Because you made it a point to come on to ST & say just that about me. You almost had me believing you about
the things youve said about AABB, but you are the one who lied. You are the one
AABB

Your Recent History

Delayed Upgrade Clock